Comprehensive Analysis of Ligand-receptor Interactions in Colon Adenocarcinoma to Identify of Tumor Microenvironment Oxidative Stress and Prognosis Model

被引:2
作者
Hu, Jun [1 ]
Zhu, Wenbo [2 ]
Wang, Wenpeng [1 ]
Yue, Xin [1 ]
Zhao, Peng [1 ]
Kong, Dalu [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Dept Colorectal Canc Surg,Key Lab Canc Prevent & T, Tianjin 300202, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Dept Pancreat Canc Surg,Key Lab Canc Prevent & The, Tianjin 300202, Peoples R China
关键词
Colon cancer; cell-cell communication; tumor microenvironment; molecular subtypes; oxidative stress; immunotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; MIGRATION INHIBITORY FACTOR; VEGF-C; THERAPEUTIC TARGET; GROWTH-FACTOR; CANCER; EXPRESSION; HYPOXIA; CELLS; MULTICENTER;
D O I
10.2174/0929867331666230821092346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Single-cell technology enables a deep study on the mechanism of cancers. This work delineated the function of ligand-receptor interaction in colon adenocarcinoma (COAD), and developed a LR pairs-based prognostic model.Methods For identifying important LR pairs, Single-cell RNA sequencing data of COAD was included. Unsupervised consensus clustering constructed molecular subtypes. LASSO established a prognostic model. Infiltration of 22 immune cells was evaluated by Cibersort. Enrichment score of oxidative stress related pathways was determined by SsGSEA in each patient.Results Forty-seven LR pairs were closely associated with the prognosis of COAD. Three molecular subtypes were differentiated according to 47 LR pairs, which displayed differential clinical features and molecular features. There were significant differences in immune T cell lytic activity among different subtypes. In clust1 with poor prognosis, significantly enriched oncogenic pathways were found, especially epithelial-mesenchymal transition (EMT). Additionally, it has been found that clust3 had significantly higher immune infiltration. A prognostic model containing eight LR pairs (PDGFB-PDGFRA, FLT4-VEGFC, CSF1R-CSF1, DLL1-NOTCH4, PDGFB-LRP1, DLL1-NOTCH3, FLT4-PDGFC, and NRP2-PGF) was established, which could effectively divide samples into low-risk and high-risk groups. Significantly higher oxidative stress was found among high-risk patients.Conclusions This study integrated expression data and single-cell data for demonstrating the effectiveness of LR pairs in establishing the prognostic model and constructing molecular subtypes. Prognostic LR pairs may contribute to tumorigenesis and progression in COAD. The prognostic model was the potential for predicting prognosis and guiding immunotherapy for COAD patients.
引用
收藏
页码:4912 / 4934
页数:23
相关论文
共 64 条
[1]   Colon Cancer: A Clinician's Perspective in 2019 [J].
Ahmed, Monjur .
GASTROENTEROLOGY RESEARCH, 2020, 13 (01) :1-10
[2]   Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma [J].
Aoki, Shuichi ;
Inoue, Koetsu ;
Klein, Sebastian ;
Halvorsen, Stefan ;
Chen, Jiang ;
Matsui, Aya ;
Nikmaneshi, Mohammad R. ;
Kitahara, Shuji ;
Hato, Tai ;
Chen, Xianfeng ;
Kawakubo, Kazumichi ;
Nia, Hadi T. ;
Chen, Ivy ;
Schanne, Daniel H. ;
Mamessier, Emilie ;
Shigeta, Kohei ;
Kikuchi, Hiroto ;
Ramjiawan, Rakesh R. ;
Schmidt, Tyge C. E. ;
Iwasaki, Masaaki ;
Yau, Thomas ;
Hong, Theodore S. ;
Quaas, Alexander ;
Plum, Patrick S. ;
Dima, Simona ;
Popescu, Irinel ;
Bardeesy, Nabeel ;
Munn, Lance L. ;
Borad, Mitesh J. ;
Sassi, Slim ;
Jain, Rakesh K. ;
Zhu, Andrew X. ;
Duda, Dan G. .
GUT, 2022, 71 (01) :185-193
[3]   Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].
Balar, Arjun V. ;
Galsky, Matthew D. ;
Rosenberg, Jonathan E. ;
Powles, Thomas ;
Petrylak, Daniel P. ;
Bellmunt, Joaquim ;
Loriot, Yohann ;
Necchi, Andrea ;
Hoffman-Censits, Jean ;
Perez-Gracia, Jose Luis ;
Dawson, Nancy A. ;
van der Heijden, Michiel S. ;
Dreicer, Robert ;
Srinivas, Sandy ;
Retz, Margitta M. ;
Joseph, Richard W. ;
Drakaki, Alexandra ;
Vaishampayan, Ulka N. ;
Sridhar, Srikala S. ;
Quinn, David I. ;
Duran, Ignacio ;
Shaffer, David R. ;
Eigl, Bernhard J. ;
Grivas, Petros D. ;
Yu, Evan Y. ;
Li, Shi ;
Kadel, Edward E., III ;
Boyd, Zachary ;
Bourgon, Richard ;
Hegde, Priti S. ;
Mariathasan, Sanjeev ;
Thastrom, AnnChristine ;
Abidoye, Oyewale O. ;
Fine, Gregg D. ;
Bajorin, Dean F. .
LANCET, 2017, 389 (10064) :67-76
[4]   Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks [J].
Blanche, Paul ;
Dartigues, Jean-Francois ;
Jacqmin-Gadda, Helene .
STATISTICS IN MEDICINE, 2013, 32 (30) :5381-5397
[5]   Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer [J].
Buechler, Matthew B. ;
Fu, Wenxian ;
Turley, Shannon J. .
IMMUNITY, 2021, 54 (05) :903-915
[6]   Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1 [J].
Cai, Hao ;
Zhang, Yichi ;
Wang, Jian ;
Gu, Jinyang .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[7]   Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy [J].
Cannarile, Michael A. ;
Weisser, Martin ;
Jacob, Wolfgang ;
Jegg, Anna-Maria ;
Ries, Carola H. ;
Ruettinger, Dominik .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[8]  
Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12
[9]   Ligand-receptor interaction atlas within and between tumor cells and T cells in lung adenocarcinoma [J].
Chen, Zhencong ;
Yang, Xiaodong ;
Bi, Guoshu ;
Lian, Jiaqi ;
Hu, Zhengyang ;
Zhao, Mengnan ;
Li, Ming ;
Lu, Tao ;
Zheng, Yuansheng ;
Sui, Qihai ;
Yang, Yong ;
Zhan, Cheng ;
Jiang, Wei ;
Wang, Qun ;
Tan, Lijie .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (12) :2205-2219
[10]   Identification of Senescence-Related Subtypes, the Development of a Prognosis Model, and Characterization of Immune Infiltration and Gut Microbiota in Colorectal Cancer [J].
Dai, Ju-Ji ;
Fu, Yang-Yang ;
Zhong, Xi-Qiang ;
Cen, Wei ;
Ye, Mao-Fei ;
Chen, Xi-Han ;
Pan, Yi-Fei ;
Ye, Le-Chi .
FRONTIERS IN MEDICINE, 2022, 9